Procter & Gamble Company (The) $PG Stock Sold by James Investment Research Inc.

James Investment Research Inc. lowered its stake in Procter & Gamble Company (The) (NYSE:PG) by 28.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 42,080 shares of the company’s stock after selling 16,524 shares during the quarter. James Investment Research Inc.’s holdings in Procter & Gamble were worth $6,113,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PG. Ellis Investment Partners LLC grew its holdings in shares of Procter & Gamble by 0.7% in the third quarter. Ellis Investment Partners LLC now owns 8,816 shares of the company’s stock worth $1,281,000 after purchasing an additional 64 shares during the last quarter. Clark Wealth Partners raised its holdings in Procter & Gamble by 20.6% during the 3rd quarter. Clark Wealth Partners now owns 387 shares of the company’s stock valued at $56,000 after buying an additional 66 shares during the last quarter. KLCM Advisors Inc. boosted its position in Procter & Gamble by 0.9% during the 1st quarter. KLCM Advisors Inc. now owns 7,890 shares of the company’s stock valued at $1,140,000 after buying an additional 70 shares during the period. Midwest Professional Planners LTD. boosted its position in Procter & Gamble by 2.6% during the 2nd quarter. Midwest Professional Planners LTD. now owns 2,799 shares of the company’s stock valued at $410,000 after buying an additional 70 shares during the period. Finally, Legacy Solutions LLC grew its holdings in Procter & Gamble by 3.8% in the 2nd quarter. Legacy Solutions LLC now owns 1,928 shares of the company’s stock worth $283,000 after acquiring an additional 71 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Susan Whaley sold 2,369 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the transaction, the insider owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. This trade represents a 7.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider owned 187,001 shares of the company’s stock, valued at $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock valued at $2,189,970 over the last three months. 0.23% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on PG shares. Citigroup boosted their price objective on shares of Procter & Gamble from $180.00 to $187.00 and gave the company a “buy” rating in a research report on Friday. UBS Group set a $166.00 price target on shares of Procter & Gamble in a research report on Friday. The Goldman Sachs Group reissued a “neutral” rating and issued a $161.00 price target on shares of Procter & Gamble in a research note on Thursday. Morgan Stanley raised their price objective on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Freedom Broker raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 price objective on the stock in a research report on Friday. Fifteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $168.90.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

Procter & Gamble Price Performance

PG opened at $161.21 on Friday. The company has a current ratio of 0.72, a quick ratio of 0.47 and a debt-to-equity ratio of 0.40. The company has a market cap of $374.43 billion, a price-to-earnings ratio of 24.28, a price-to-earnings-growth ratio of 4.11 and a beta of 0.39. The stock has a fifty day simple moving average of $148.41 and a two-hundred day simple moving average of $147.09. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25.

Procter & Gamble (NYSE:PG) last announced its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The firm had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. The company’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.99 EPS. Research analysts predict that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is 65.71%.

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.